Literature DB >> 1310678

Reconstitution of the multiprotein complex of pp60src, hsp90, and p50 in a cell-free system.

K A Hutchison1, B K Brott, J H De Leon, G H Perdew, R Jove, W B Pratt.   

Abstract

A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the pp60src tyrosine kinase and hsp90. Reticulocyte lysate forms complexes between hsp90 and a temperature-sensitive mutant of Rous sarcoma virus pp60v-src, which is normally present in cytosol virtually entirely in the multiprotein complex form. In addition, hsp90 in the lysate complexes with wild-type pp60v-src, of which only a small portion is normally recovered in cytosol in the native multiprotein complex, and with the cellular homolog, pp60c-src, which has never been recovered in cytosol in the form of a native multiprotein complex with hsp90. Moreover, the reticulocyte lysate-reconstituted complex also contains the 50-kDa phosphoprotein component of the native pp60v-src multiprotein complex. The native and reconstituted pp60src-hsp90 complexes have similar thermal stability and, like steroid receptor heterocomplexes, they are stabilized by molybdate. As previously shown with reticulocyte lysate-reconstituted steroid receptor heteroprotein complexes, the reconstituted pp60src multiprotein complex contains hsp70, which is a major candidate for providing the protein unfoldase activity required for hsp90 association.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310678

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

Review 1.  Macrocyclic inhibitors of hsp90.

Authors:  Victoria A Johnson; Erinprit K Singh; Lidia A Nazarova; Leslie D Alexander; Shelli R McAlpine
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

2.  A cell-based screen for inhibitors of protein folding and degradation.

Authors:  Frank Boschelli; Jennifer M Golas; Roseann Petersen; Vincent Lau; Lei Chen; Diane Tkach; Qiang Zhao; Dave S Fruhling; Hao Liu; Chaneun Nam; Kim T Arndt
Journal:  Cell Stress Chaperones       Date:  2010-08-19       Impact factor: 3.667

3.  The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues.

Authors:  L Stepanova; M Finegold; F DeMayo; E V Schmidt; J W Harper
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  The ability of the immunophilin FKBP59-HBI to interact with the 90-kDa heat shock protein is encoded by its tetratricopeptide repeat domain.

Authors:  C Radanyi; B Chambraud; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids.

Authors:  J Hu; D O Toft; C Seeger
Journal:  EMBO J       Date:  1997-01-02       Impact factor: 11.598

6.  HEAT SHOCK PROTEIN 90C is a bona fide Hsp90 that interacts with plastidic HSP70B in Chlamydomonas reinhardtii.

Authors:  Felix Willmund; Michael Schroda
Journal:  Plant Physiol       Date:  2005-07-01       Impact factor: 8.340

Review 7.  Chaperones in cell cycle regulation and mitogenic signal transduction: a review.

Authors:  K Helmbrecht; E Zeise; L Rensing
Journal:  Cell Prolif       Date:  2000-12       Impact factor: 6.831

8.  CDC37 is required for p60v-src activity in yeast.

Authors:  B Dey; J J Lightbody; F Boschelli
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

9.  Heat-shock protein hsp90 governs the activity of pp60v-src kinase.

Authors:  Y Xu; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent.

Authors:  D F Smith; L Whitesell; S C Nair; S Chen; V Prapapanich; R A Rimerman
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.